Xometry (NASDAQ:XMTR) Price Target Raised to $130.00

Xometry (NASDAQ:XMTR – Free Report) had its target price lifted by Rosenblatt Securities from $120.00 to $130.00 in a report issued on Wednesday,Benzinga reports. They currently have a buy rating on the stock.

Several other analysts have also recently issued reports on XMTR. Cantor Fitzgerald reaffirmed an “overweight” rating on shares of Xometry in a research note on Tuesday, October 27th. Wedbush boosted their target price on Xometry from $126.00 to $140.00 and gave the stock an “outperform” rating in a report on Wednesday. Royal Bank Of Canada upped their price target on Xometry from $85.00 to $100.00 and gave the company a “sector perform” rating in a research report on Wednesday, August 5th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Xometry in a report on Wednesday, August 26th. Finally, Citigroup reiterated a “market outperform” rating on shares of Xometry in a research report on Monday, September 21st. Eight equities research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $123.64.

View Our Latest Stock Analysis on XMTR

Xometry Price Performance

XMTR stock traded up $5.94 during midday trading on Wednesday, reaching $114.95. The stock had a trading volume of 1,101,668 shares, compared to its average volume of 746,134. The company’s fifty day simple moving average is $98.21 and its 200 day simple moving average is $77.22. The company has a current ratio of 3.21, a quick ratio of 3.20 and a debt-to-equity ratio of 0.41. The company has a market cap of $5.96 billion, a price-to-earnings ratio of -338.08 and a beta of 1.33. Xometry has a 52-week low of $35.86 and a 52-week high of $117.94.

Xometry (NASDAQ:XMTR – Get Free Report) last released its earnings results on Tuesday, November 3rd. The company reported $0.28 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.19 by $0.09. The business had revenue of $252.44 million during the quarter, compared to analyst estimates of $235.54 million. Xometry had a negative net margin of 3.82% and a negative return on equity of 2.88%. The company’s revenue for the quarter was up 39.5% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.11 earnings per share. As a group, sell-side analysts predict that Xometry will post -0.01 earnings per share for the current fiscal year.

Insider Activity at Xometry

In other news, Director Fabio Rosati sold 8,100 shares of the stock in a transaction that occurred on Monday, August 10th. The shares were sold at an average price of $91.45, for a total value of $740,745.00. Following the completion of the sale, the director owned 93,567 shares of the company’s stock, valued at $8,556,702.15. This represents a 7.97% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CTO Vaidyanathan Raghavan sold 5,000 shares of the firm’s stock in a transaction that occurred on Thursday, August 27th. The stock was sold at an average price of $96.77, for a total transaction of $483,850.00. Following the sale, the chief technology officer owned 135,777 shares of the company’s stock, valued at $13,139,140.29. This represents a 3.55% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 73,199 shares of company stock valued at $7,126,855 over the last ninety days. Corporate insiders own 9.10% of the company’s stock.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the business. Wellington Management Group LLP grew its position in Xometry by 26.9% in the second quarter. Wellington Management Group LLP now owns 1,322,581 shares of the company’s stock worth $127,656,000 after acquiring an additional 280,491 shares during the period. Allspring Global Investments Holdings LLC lifted its stake in shares of Xometry by 243.6% in the 1st quarter. Allspring Global Investments Holdings LLC now owns 694,390 shares of the company’s stock valued at $29,015,000 after purchasing an additional 492,285 shares during the last quarter. Sylebra Capital LLC grew its holdings in shares of Xometry by 31.3% during the 1st quarter. Sylebra Capital LLC now owns 535,624 shares of the company’s stock worth $21,875,000 after purchasing an additional 127,637 shares during the period. Zevenbergen Capital Investments LLC grew its holdings in shares of Xometry by 115.1% during the 3rd quarter. Zevenbergen Capital Investments LLC now owns 297,552 shares of the company’s stock worth $30,603,000 after purchasing an additional 159,227 shares during the period. Finally, Sei Investments Co. increased its position in shares of Xometry by 45.6% during the 1st quarter. Sei Investments Co. now owns 274,641 shares of the company’s stock worth $11,216,000 after purchasing an additional 85,989 shares during the last quarter. 97.31% of the stock is currently owned by institutional investors and hedge funds.

Xometry News Roundup

Here are the key news stories impacting Xometry this week:

Xometry Company Profile

(Get Free Report)

Xometry, Inc (NASDAQ:XMTR) operates a technology-driven marketplace that connects businesses seeking custom parts with a network of manufacturing suppliers. Its platform uses automated pricing, manufacturability analysis and digital workflows to help customers source parts and manage production more efficiently.

The company supports a range of manufacturing processes, including CNC machining, 3D printing, sheet metal fabrication, injection molding, urethane casting and other specialized production services.

Further Reading

Analyst Recommendations for Xometry (NASDAQ:XMTR)

Receive News & Ratings for Xometry Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xometry and related companies with MarketBeat.com's FREE daily email newsletter.